Following the United Kingdom's withdrawal from the European Union, all medical devices placed on the Great Britain market need to be registered with the MHRA. The CE marking continues to be recognized until 30 June 2023, but devices must complete registration with the MHRA during a certain period of grace to be legally maintained on the UK market. With the confirmation of registration announced today, Redsense complies with the new requirements.

"The timely registration with the MHRA ensures our continued access to the vital UK market, and we welcome the smooth transition. This means that we are good to go,"says Patrik Byhmer, CEO of Redsense Medical AB.